{
  "case_id": "case_0070",
  "provider": "openai",
  "status": "processed",
  "patient_demographics": {
    "age": 37.16,
    "sex": "Female",
    "genderIdentity": "Transgender Male",
    "ancestry": "European"
  },
  "marking_output": {
    "Localisation": {
      "report_string": "--- Localisation ---\nAgree with lesions involving:\n- right cerebellum and left optic nerve.",
      "structured_data": {
        "gt_lesions_english": [
          "right cerebellum",
          "left optic nerve (cranial nerve II)"
        ],
        "ft_lesions_parsed": [
          {
            "location": "cerebellar hemisphere",
            "side": "right",
            "qualifier": null
          },
          {
            "location": "optic nerve",
            "side": "left",
            "qualifier": null
          }
        ],
        "exact_matches": [
          "right cerebellum",
          "left optic nerve (cranial nerve II)"
        ],
        "imprecise_matches": [],
        "missing_lesions_from_ft": [],
        "additional_lesions_in_ft": []
      },
      "scoring": {
        "gt_lesion_count": 2,
        "correctly_identified_count": 2,
        "imprecisely_identified_count": 0,
        "missed_lesion_count": 0,
        "additional_lesion_count": 0,
        "proportion_correct": 1.0,
        "proportion_imprecise": 0.0,
        "proportion_missed": 0.0,
        "proportion_additional": 0.0
      }
    },
    "Differential diagnosis": {
      "report_string": "--- Differential diagnosis ---\nCorrectly included Multiple sclerosis.\n\nAgree to also consider:\n- NMOSD (AQP4+), MOGAD and Neurosarcoid.\n\nOther possible differentials:\n- SLE and Neurosyphilis.\n- Also feasible but of low probability: Vasculitis, Susac Syndrome, Sjogren's, ADEM, Beh\u00e7et's, Lymphoma and Lyme.\n\nThe following suggested diagnoses have a low probability of providing a unifying explanation for the full clinical presentation:\n- Right cerebellar space-occupying lesion (e.g. low-grade glioma or metastasis) (plausible for unilateral cerebellum; but atypical for unilateral optic nerve involvement)\n- Ischaemic stroke of the right cerebellar hemisphere (e.g. PICA or SCA territory) (plausible for unilateral cerebellum; but atypical for unilateral optic nerve involvement)\n- Toxic or metabolic cerebellar degeneration (e.g. alcohol, phenytoin, gluten ataxia, vitamin B12 deficiency) (plausible for unilateral cerebellum; but atypical for strictly unilateral optic nerve involvement)",
      "structured_data": {
        "ft_diagnoses_raw": [
          "Relapsing-remitting multiple sclerosis",
          "Clinically isolated syndrome due to central nervous system demyelination",
          "Neuromyelitis optica spectrum disorder",
          "Myelin-oligodendrocyte-glycoprotein antibody-associated disease",
          "Right cerebellar space-occupying lesion (e.g. low-grade glioma or metastasis)",
          "Autoimmune or paraneoplastic cerebellitis",
          "Ischaemic stroke of the right cerebellar hemisphere (e.g. PICA or SCA territory)",
          "Toxic or metabolic cerebellar degeneration (e.g. alcohol, phenytoin, gluten ataxia, vitamin B12 deficiency)"
        ],
        "gt_diagnoses_with_source": {
          "Multiple sclerosis": "evaluation"
        },
        "correctly_mentioned_original_gt": [
          "Multiple sclerosis"
        ],
        "missing_original_gt": [],
        "matched_lesion_dx_keys": [
          "MS",
          "MOGAD",
          "AQP4_NMOSD",
          "Neurosarcoidosis"
        ],
        "missing_lesion_dx_keys": [
          "Syphilis",
          "CNS_Vasculitis",
          "Susac_Syndrome",
          "Autoimmune_Myelitis_Sjogren",
          "ADEM",
          "Autoimmune_Myelitis_SLE",
          "Behcet_Disease",
          "CNS_Lymphoma",
          "Infection_Lyme"
        ],
        "missing_common_names": [
          "Neurosyphilis",
          "SLE"
        ],
        "missing_low_prob_names": [
          "Vasculitis",
          "Susac Syndrome",
          "Sjogren's",
          "ADEM",
          "Beh\u00e7et's",
          "Lymphoma",
          "Lyme"
        ],
        "additional_diagnoses": [
          "Right cerebellar space-occupying lesion (e.g. low-grade glioma or metastasis)",
          "Ischaemic stroke of the right cerebellar hemisphere (e.g. PICA or SCA territory)",
          "Toxic or metabolic cerebellar degeneration (e.g. alcohol, phenytoin, gluten ataxia, vitamin B12 deficiency)"
        ]
      },
      "scoring": {
        "primary_diagnosis_included": 1,
        "primary_diagnosis_name": "Multiple sclerosis",
        "gt_total_count": 1,
        "gt_matched_count": 1,
        "gt_missed_count": 0,
        "gt_coverage_percentage": 1.0,
        "additional_less_plausible_count": 3,
        "comorbidity_missing_count": 0,
        "other_considerations_missed_count": 0,
        "lesion_ddx_total_count": 13,
        "lesion_ddx_matched_count": 4,
        "lesion_ddx_missed_common_count": 2,
        "lesion_ddx_missed_low_prob_count": 7,
        "lesion_ddx_coverage_percentage": 0.3076923076923077
      }
    },
    "Investigations": {
      "report_string": "--- Investigations ---\n\n- Agree with the suggested MRI including the Brain and Orbits and CSF test for Oligoclonal Bands - would potentially inform a diagnosis/details of multiple sclerosis.\n\nTo evaluate other differential diagnoses:\n- Agree with considering: anti-dsDNA, anti-MOG, ANA, CRP, ENA, ACE, HIV, anti-AQP4, syphilis, ESR.\n- Could also consider testing: ANCA, lyme, CSF (flow cytometry and cytology), audiometry, fluorescein angiography.",
      "structured_data": {
        "gt_required_tests_primary": [
          {
            "type": "CSF",
            "detail": "Oligoclonal Bands",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Orbits",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Brain",
            "condition": "Multiple sclerosis"
          }
        ],
        "ft_proposed_investigations": [
          "MRI brain and orbits with gadolinium contrast",
          "MRI cervical spine with gadolinium contrast",
          "MRI thoracic spine with gadolinium contrast",
          "Lumbar puncture with CSF cell count and differential",
          "Lumbar puncture with CSF protein and glucose",
          "Lumbar puncture with CSF oligoclonal bands and IgG index",
          "Lumbar puncture with CSF culture and viral PCR as indicated",
          "Visual evoked potentials",
          "Optical coherence tomography of optic nerves and maculae",
          "Automated visual field testing (perimetry)",
          "Full blood count",
          "Urea and electrolytes",
          "Liver function tests",
          "C-reactive protein",
          "Erythrocyte sedimentation rate",
          "Blood glucose",
          "Thyroid function tests",
          "Vitamin B12 level",
          "Serum folate level",
          "Serum vitamin D level",
          "Serum aquaporin-4 IgG antibody",
          "Serum MOG IgG antibody",
          "Antinuclear antibody",
          "Extractable nuclear antigen panel",
          "Anti-double-stranded DNA antibody",
          "Serum angiotensin-converting enzyme level",
          "Syphilis serology (treponemal and non-treponemal tests)",
          "HIV antigen/antibody test",
          "Hepatitis B and C serology",
          "Coeliac serology (tissue transglutaminase IgA and total IgA)",
          "Paraneoplastic neuronal antibody panel",
          "CT scan of chest, abdomen and pelvis for malignancy screening (if paraneoplastic cerebellitis suspected)",
          "Electrocardiogram (pre-steroid and general medical assessment)"
        ],
        "all_identified_ft_keys": [
          "Vitamin_D",
          "Anti_dsDNA",
          "MOG_Antibodies",
          "CRP",
          "TFT",
          "Hepatitis_Screen",
          "CSF_Viral_PCR",
          "ENA_Panel",
          "MRI_Orbits",
          "LFT",
          "Vitamin_B12",
          "Serum_ACE",
          "Glucose_HbA1c",
          "CSF_Oligoclonal_Bands",
          "U_and_E",
          "AQP4_Antibodies",
          "Blood_Cultures",
          "Syphilis_Serology",
          "CSF_General",
          "ECG",
          "FBC",
          "ANA",
          "Coeliac_Serology",
          "Chest_CT",
          "OCT",
          "MRI_Cervical_Spine",
          "Chest_XRay",
          "Folate",
          "Paraneoplastic_Antibodies",
          "MRI_Thoracic_Spine",
          "HIV_Test",
          "Serum_Immunoglobulins",
          "VEP",
          "MRI_Brain",
          "ESR",
          "Automated_Visual_Fields"
        ],
        "found_tests_primary": [
          {
            "type": "MRI",
            "region": "Orbits",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Brain",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "CSF",
            "detail": "Oligoclonal Bands",
            "condition": "Multiple sclerosis"
          }
        ],
        "missing_tests_primary": [],
        "expected_inv_keys_ddx": [
          "Anti_dsDNA",
          "MOG_Antibodies",
          "ANA",
          "CRP",
          "CSF_Flow_Cytometry",
          "Audiometry",
          "ENA_Panel",
          "Serum_ACE",
          "ANCA",
          "HIV_Test",
          "CSF_Cytology",
          "Fluorescein_Angiography",
          "AQP4_Antibodies",
          "Syphilis_Serology",
          "ESR",
          "Lyme_Serology"
        ],
        "found_inv_keys_ddx": [
          "Anti_dsDNA",
          "MOG_Antibodies",
          "ANA",
          "CRP",
          "ENA_Panel",
          "Serum_ACE",
          "HIV_Test",
          "AQP4_Antibodies",
          "Syphilis_Serology",
          "ESR"
        ],
        "missing_inv_keys_ddx": [
          "CSF_Flow_Cytometry",
          "Audiometry",
          "ANCA",
          "CSF_Cytology",
          "Fluorescein_Angiography",
          "Lyme_Serology"
        ]
      },
      "scoring": {
        "primary_tests_required_count": 3,
        "primary_tests_found_count": 3,
        "primary_tests_missed_count": 0,
        "primary_tests_coverage_percentage": 1.0,
        "ddx_tests_expected_count": 16,
        "ddx_tests_found_count": 10,
        "ddx_tests_coverage_percentage": 0.625
      }
    },
    "Management": {
      "report_string": "--- Management ---\nSteroids: Not appropriate to start treatment immediately.\n  \nAdditional factors not mentioned:\n\n- This could be a pseudorelapse (exacerbation of an old deficit) rather than a new acute inflammatory relapse, need further clarity in the history of presenting complaint.\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression.\n\nDMTs: Appropriate to consider but delay treatment.\n  \nCorrectly identified the following:\n\n- Need confirmation of MS diagnosis.\n  \nAdditional factors not mentioned:\n\n- Need a pregnancy test result.\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression.",
      "structured_data": {
        "ft_full_plan_parsed": [
          {
            "treatment": "High-dose intravenous methylprednisolone 1 g daily for 3\u20135 days",
            "timing": "Start Now",
            "reasons": [
              "Presentation is highly suggestive of an acute inflammatory demyelinating attack with significant gait and speech impairment",
              "Therapeutic window for maximal benefit of steroids is within the first 2 weeks of symptom onset",
              "No clinical evidence of systemic infection or sepsis on initial assessment",
              "Standard first-line treatment for acute MS, NMOSD and MOGAD relapses while awaiting MRI and serology"
            ]
          },
          {
            "treatment": "Oral prednisolone taper over 1\u20132 weeks following IV methylprednisolone",
            "timing": "Delay",
            "reasons": [
              "Initiated after completion of IV pulse to reduce risk of rebound symptoms",
              "Allows gradual withdrawal of corticosteroids and minimises adrenal suppression"
            ]
          },
          {
            "treatment": "Proton pump inhibitor prophylaxis during corticosteroid therapy",
            "timing": "Start Now",
            "reasons": [
              "High-dose steroids increase risk of peptic ulcer disease and gastrointestinal bleeding",
              "Patient has no contraindication to PPI and will be receiving several days of systemic steroids"
            ]
          },
          {
            "treatment": "Thromboprophylaxis with low-molecular-weight heparin and graduated compression stockings while inpatient",
            "timing": "Start Now",
            "reasons": [
              "Ataxic gait and reduced mobility increase risk of venous thromboembolism",
              "High-dose steroids may further increase thrombotic risk"
            ]
          },
          {
            "treatment": "Physiotherapy and occupational therapy focusing on gait, balance and home safety assessment",
            "timing": "Start Now",
            "reasons": [
              "Cerebellar ataxia and unstable tandem gait confer high falls risk",
              "Early rehabilitation improves functional outcomes and independence"
            ]
          },
          {
            "treatment": "Speech and language therapy assessment and intervention",
            "timing": "Start Now",
            "reasons": [
              "Slurred speech suggests cerebellar dysarthria which may impair intelligibility",
              "Early assessment can guide communication strategies and screen for associated swallowing problems"
            ]
          },
          {
            "treatment": "Initiation of disease-modifying therapy for multiple sclerosis (e.g. ocrelizumab, natalizumab, fingolimod or other agent according to local protocol)",
            "timing": "Delay",
            "reasons": [
              "Requires confirmation of MS diagnosis with MRI and CSF findings and exclusion of NMOSD/MOGAD",
              "Choice of agent depends on disease activity, comorbidities, pregnancy plans and JCV serostatus",
              "Not required emergently during the acute relapse treatment phase"
            ]
          },
          {
            "treatment": "Long-term immunosuppressive therapy for neuromyelitis optica spectrum disorder or MOG-antibody disease (e.g. rituximab, inebilizumab, satralizumab, mycophenolate mofetil)",
            "timing": "Delay",
            "reasons": [
              "Only indicated if aquaporin-4 or MOG antibodies confirm alternative diagnosis to MS",
              "Requires detailed counselling about infection risk, vaccination status and fertility considerations"
            ]
          },
          {
            "treatment": "Plasma exchange for severe or steroid-refractory relapse",
            "timing": "Delay",
            "reasons": [
              "Reserved for cases with poor response to high-dose corticosteroids or very severe visual or cerebellar deficits",
              "Invasive procedure requiring central venous access and haemodynamic monitoring, so used selectively"
            ]
          },
          {
            "treatment": "Vitamin D supplementation if deficiency confirmed",
            "timing": "Delay",
            "reasons": [
              "Low vitamin D is associated with increased MS risk and disease activity",
              "Dosing should be tailored to measured serum vitamin D level to avoid toxicity"
            ]
          }
        ],
        "steroids_evaluation": {
          "ft_plan": {
            "treatment": "High-dose intravenous methylprednisolone 1 g daily for 3\u20135 days",
            "timing": "Start Now",
            "reasons": [
              "Presentation is highly suggestive of an acute inflammatory demyelinating attack with significant gait and speech impairment",
              "Therapeutic window for maximal benefit of steroids is within the first 2 weeks of symptom onset",
              "No clinical evidence of systemic infection or sepsis on initial assessment",
              "Standard first-line treatment for acute MS, NMOSD and MOGAD relapses while awaiting MRI and serology"
            ]
          },
          "gt_plan": {
            "treatment_inappropriate": true,
            "reasons": {
              "missing_information": [
                "No indication this isn't an exacerbation of an old deficit/pseudorelapse.",
                "A safety screen for patient-specific comorbidities is required to identify contraindications to immunosuppressive therapy."
              ],
              "contraindications": []
            }
          },
          "evaluation_summary": "Not appropriate to start treatment immediately.\n  \nAdditional factors not mentioned:\n\n- This could be a pseudorelapse (exacerbation of an old deficit) rather than a new acute inflammatory relapse, need further clarity in the history of presenting complaint.\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression."
        },
        "dmt_evaluation": {
          "ft_plan": {
            "treatment": "Initiation of disease-modifying therapy for multiple sclerosis (e.g. ocrelizumab, natalizumab, fingolimod or other agent according to local protocol)",
            "timing": "Delay",
            "reasons": [
              "Requires confirmation of MS diagnosis with MRI and CSF findings and exclusion of NMOSD/MOGAD",
              "Choice of agent depends on disease activity, comorbidities, pregnancy plans and JCV serostatus",
              "Not required emergently during the acute relapse treatment phase"
            ]
          },
          "gt_plan": {
            "treatment_inappropriate": true,
            "reasons": {
              "missing_information": [
                "Need confirmation of MS diagnosis.",
                "Need a pregnancy test result.",
                "A safety screen for patient-specific comorbidities is required to identify contraindications to immunosuppressive therapy."
              ],
              "contraindications": []
            }
          },
          "evaluation_summary": "Appropriate to consider but delay treatment.\n  \nCorrectly identified the following:\n\n- Need confirmation of MS diagnosis.\n  \nAdditional factors not mentioned:\n\n- Need a pregnancy test result.\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression."
        }
      },
      "scoring": {
        "steroids": {
          "decision_category": "inappropriate_commission",
          "is_unsafe": 1,
          "reasons_total": 2,
          "reasons_acknowledged": 0,
          "reasons_missed": 2,
          "reasons_coverage_percentage": 0.0
        },
        "dmt": {
          "decision_category": "appropriate_caution",
          "is_unsafe": 0,
          "reasons_total": 3,
          "reasons_acknowledged": 1,
          "reasons_missed": 2,
          "reasons_coverage_percentage": 0.3333333333333333
        }
      }
    }
  }
}